A Clinical Collaboration to Fuel the Healthcare Market Image Credits: Seeking Alpha Announcement Summit Therapeutics Inc., a biopharmaceutical oncology company, and Revolution Medicines Inc., a leading clinical oncology company, have entered into a clinical collaboration. Revolution medicines m...
HUTCHMED Received Approval from China Image Credits: Sharecast Announcement HUTCHMED (China) Limited has received approval from the China National Medical Products Administration (NMPA) for its new drug application merging TAGRISSO® (osimertinib) and ORPATHYS® (savolitinib). The approva...
Riliprubart Received Orphan Drug Designation in Japan Image Credits: Western Slope Now Announcement The Japanese Ministry of Health, Labour and Welfare appointed riliprubart as an orphan drug designation. Riliprubart is a monoclonal antibody suppressing active C1s in the classical complement fo...
ESTEVE’s Agreement with Sanofi Image Credits: AInvest Announcement ESTEVE signed an agreement with Sanofi, a French multinational pharmaceutical and health-care company, to acquire Caprelsa® (vandetanib) rights in over 50 countries and more. It’s a treatment that applies to chil...
June Wrap-up with Approvals Image Credits: Biospace Approvals The FDA recently granted approvals for UroGen and RSV immunization. With the approval, Moderna expands mRNA RSV shot. On 13th June 2025, the FDA confirmed Moderna’s mRNA vaccine, mResvia, for respiratory syncytial virus, a solu...
Orphalan Partners to Donate and Ensure Access to all Communities Image Credits: Wilson Disease Org Announcement Orphalan SA, a pharmaceutical company targeting rare diseases, announced its partnership with MAP International and the Wilson Disease Association (WDA). This alliance will enable acc...
FUJIFILM VisualSonics’ Smart Patform for Preclinical Ultrasound Image Credits: Imaging Technology News Announcement FUJIFILM VisualSonics Inc., popular in photoacoustic imaging systems and ultra-high frequency ultrasound, launched the Vevo F2 LAZR-X20 photoacoustic imaging platform. It is...
Pendopharm® and Kalvista® Collaborate to Broaden Treatment in Canada Image Credits: AInvest Announcement Pendopharm®, a part of Pharmascience Inc., has signed a distribution agreement with Kalvista Pharmaceuticals Inc., a leading biopharmaceutical company known for its development i...
Orano Med’s Expansion in Texas Announcement Orano Group’s subsidiary, Orano Med, expanded its Research and Development center to Plano, Texas (US) the new center, inaugurated to provide facilities for preclinical research and the development of radiopharmaceuticals. The center will f...
Avvio’s Certification Marked a New Phase in Global Transformation Image Credits: Avvio Medical Announcement Avvio Medical Inc., a private medical device company focused on treating kidney stone diseases, has received an ISO 13485:2016 certification for its audit, introduced by BSI (Britis...
